Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.423, 2003-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Letrozole exerts "slight economic advantage" over anastrozole in breast cancer
Inpharma, Vol. 1, Iss. 1398, 2003-01 ,pp. :
Access to resources
Recommend
Comparative review of anastrozole, letrozole and exemestane in the management of early breast cancer
By Nabholtz Jean-Marc Mouret-Reynier Marie-Ange Durando Xavier Van Praagh Isabelle Al-Sukhun Sana Ferriere Jean-Pierre Chollet Philippe
Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 9, 2009-06 ,pp. :
Anastrozole in the management of breast cancer
By Reese David Nabholtz Jean-Marc
Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 9, 2002-09 ,pp. :
Anastrozole: In Early Breast Cancer
Drugs, Vol. 62, Iss. 17, 2002-01 ,pp. :
Letrozole in the treatment of breast cancer
By Ellis Matthew J Shaw Heather S
Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 5, 2002-05 ,pp. :